FUROSCIX
These highlights do not include all the information needed to use FUROSCIX safely and effectively. See full prescribing information for FUROSCIX. Furoscix® (furosemide injection), for subcutaneous use Initial U.S. Approval: 1968
Approved
Approval ID
eac958dd-8d43-e44e-e053-2995a90a4d5e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 30, 2023
Manufacturers
FDA
scPharmaceuticals Inc.
DUNS: 079386513
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
furosemide injection 80 mg/ 10 mL
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71767-100
Application NumberNDA209988
Product Classification
M
Marketing Category
C73594
G
Generic Name
furosemide injection 80 mg/ 10 mL
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateNovember 30, 2023
FDA Product Classification
INGREDIENTS (1)
FUROSEMIDEActive
Quantity: 8 mg in 1 mL
Code: 7LXU5N7ZO5
Classification: ACTIB